🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients

RecruitingNAAges 18 Years - 65 YearsAllUniversity Hospital, Tours
NCT05329363 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms. Psychoeducation can improve therapeutic alliance and medication compliance. In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation. The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years * Patient with a diagnosed and reported schizophrenic disorder announced : * Schizophrenia * Schizoaffective disorder * Or a diagnosed and reported Delusional Disorder * Express written consent by the participant after receiving information about the study * Be able to communicate verbally * Participant affiliated to a social security scheme Exclusion Criteria: * Pregnant or breastfeeding woman * Patient who does not speak French * Participation in a psycho-education group in the last 2 years * Patient under legal protection or guardianship
💊

What it tests

  • PEPITS Programme
  • Usual care
📍

Where

11 sites
Serrvice de Psychiatrie
Blois, France
Service de psychiatrie
Chinon, France
Service de psychiatrie
Dreux, France
Service de psychiatrie
Fleury-les-Aubrais, France
Service de psychiatrie
La Roche-sur-Yon, France
Service de psychiatrie
Neuilly-sur-Marne, France
Service de psychiatrie
Rennes, France
Service de psychiatrie
Saint-Maurice, France

…and 3 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy